Induction NN B-NP of IN B-PP NF-KB NN B-NP during IN B-PP monocyte NN B-NP differentiation NN I-NP by IN B-PP HIV NN B-NP type NN I-NP 1 CD I-NP infection NN I-NP . . O The DT B-NP production NN I-NP of IN B-PP human JJ B-NP immunodeficiency NN I-NP virus NN I-NP type NN I-NP 1 CD I-NP ( ( O HIV-1 NN B-NP ) ) O progeny NN B-NP was VBD B-VP followed VBN I-VP in IN B-PP the DT B-NP U937 NN I-NP promonocytic JJ I-NP cell NN I-NP line NN I-NP after IN B-PP stimulation NN B-NP either CC B-PP with IN I-PP retinoic JJ B-NP acid NN I-NP or CC O PMA NN B-NP COMMA COMMA O and CC O in IN B-PP purified VBN B-NP human JJ I-NP monocytes NNS B-NP and CC O macrophages NNS B-NP . . O Electrophoretic JJ B-NP mobility NN I-NP shift NN I-NP assays NNS I-NP and CC O Southwestern NN B-NP blotting NN I-NP experiments NNS I-NP were VBD B-VP used VBN I-VP to TO B-VP detect VB I-VP the DT B-NP binding NN I-NP of IN B-PP cellular JJ B-NP transactivation NN I-NP factor NN I-NP NF-KB NN I-NP to TO B-PP the DT B-NP double JJ I-NP repeat-KB JJ I-NP enhancer NN I-NP sequence NN I-NP located JJ B-ADJP in IN B-PP the DT B-NP long JJ I-NP terminal JJ I-NP repeat NN I-NP . . O PMA NN B-NP treatment NN I-NP COMMA COMMA O and CC B-CONJP not RB I-CONJP retinoic JJ B-NP acid NN I-NP treatment NN I-NP of IN B-PP the DT B-NP U937 NN I-NP cells NNS I-NP acts VBZ B-VP in IN B-PP inducing VBG B-VP NF-KB NN B-NP expression NN I-NP in IN B-PP the DT B-NP nuclei NNS I-NP . . O In IN B-PP nuclear JJ B-NP extracts NNS I-NP from IN B-PP monocytes NNS B-NP or CC O macrophages NNS B-NP COMMA COMMA O induction NN B-NP of IN B-PP NF-KB NN B-NP occurred VBD B-VP only RB B-SBAR if IN I-SBAR the DT B-NP cells NNS I-NP were VBD B-VP previously RB I-VP infected VBN I-VP with IN B-PP HIV-1 NN B-NP . . O When WRB B-ADVP U937 NN B-NP cells NNS I-NP were VBD B-VP infected VBN I-VP with IN B-PP HIV-1 NN B-NP COMMA COMMA O no DT B-NP induction NN I-NP of IN B-PP NF-KB NN B-NP factor NN I-NP was VBD B-VP detected VBN I-VP COMMA COMMA O whereas IN O high JJ B-NP level NN I-NP of IN B-PP progeny NN B-NP virions NNS I-NP was VBD B-VP produced VBN I-VP COMMA COMMA O suggesting VBG B-VP that IN B-SBAR this DT B-NP factor NN I-NP was VBD B-VP not RB I-VP required VBN I-VP for IN B-PP viral JJ B-NP replication NN I-NP . . O These DT B-NP results NNS I-NP indicate VBP B-VP that IN B-SBAR in IN B-PP monocytic JJ B-NP cell NN I-NP lineage NN I-NP COMMA COMMA O HIV-1 NN B-NP could MD B-VP mimic VB I-VP some DT O differentiation\/activation JJ B-NP stimuli NNS B-NP allowing VBG B-VP nuclear JJ B-NP NF-KB NN I-NP expression NN I-NP . . O Positive JJ B-NP and CC I-NP negative JJ I-NP regulation NN I-NP of IN B-PP immunoglobulin NN B-NP gene NN I-NP expression NN I-NP by IN B-PP a DT B-NP novel JJ I-NP B-cell-specific JJ I-NP enhancer NN I-NP element NN I-NP . . O A DT B-NP new JJ I-NP B-cell-specific JJ I-NP enhancer NN I-NP element NN I-NP has VBZ B-VP been VBN I-VP identified VBN I-VP 3' JJ B-NP of IN B-PP E4 NN B-NP and CC O the DT B-NP octamerlike JJ I-NP motifs NNS I-NP in IN B-PP the DT B-NP human JJ I-NP immunoglobulin NN I-NP heavy-chain NN I-NP gene NN I-NP enhancer NN I-NP . . O Tandem JJ B-NP copies NNS I-NP of IN B-PP this DT B-NP 67-bp JJ I-NP MnlI-AluI NN I-NP fragment NN I-NP COMMA COMMA O when WRB B-ADVP fused VBN B-VP to TO B-PP the DT B-NP chloramphenicol JJ I-NP acetyltransferase NN I-NP gene NN I-NP driven VBN B-VP by IN B-PP the DT B-NP conalbumin JJ I-NP promoter NN I-NP COMMA COMMA O stimulated VBD B-VP transcription NN B-NP in IN B-PP B NN B-NP cells NNS I-NP but CC B-PP not RB B-PP in IN I-PP Jurkat NN B-NP T NN I-NP cells NNS I-NP or CC O HeLa NN B-NP cells NNS I-NP . . O Footprinting NN B-NP analysis NN I-NP revealed VBD B-VP that IN B-SBAR the DT B-NP identical JJ I-NP sequence NN I-NP CCGAAACTGAAAAGG NN I-NP COMMA COMMA O designated VBN B-VP E6 NN B-NP COMMA COMMA O was VBD B-VP protected VBN I-VP by IN B-PP nuclear JJ B-NP extracts NNS I-NP from IN B-PP B NN B-NP cells NNS I-NP COMMA COMMA O T NN B-NP cells NNS I-NP COMMA COMMA O or CC O HeLa NN B-NP cells NNS I-NP . . O Gel NN B-NP mobility NN I-NP shift NN I-NP assays NNS I-NP using VBG B-VP a DT B-NP synthetic JJ I-NP E6 NN I-NP motif NN I-NP detected VBD B-VP a DT B-NP B-cell-specific JJ I-NP complex NN I-NP in IN B-PP addition NN I-PP to TO I-PP a DT B-NP ubiquitous JJ I-NP band NN I-NP found VBN B-VP also RB B-PP in IN I-PP T NN B-NP cells NNS I-NP and CC O HeLa NN B-NP cells NNS I-NP . . O In IN B-PP agreement NN I-PP with IN I-PP the DT B-NP results NNS I-NP of IN B-PP gel NN B-NP retardation NN I-NP assays NNS I-NP COMMA COMMA O tandem JJ B-NP copies NNS I-NP of IN B-PP the DT B-NP E6 NN I-NP motif NN I-NP stimulated VBD B-VP transcription NN B-NP in IN B-PP ARH77 NN B-NP and CC O Raji NN B-NP cells NNS B-NP but CC B-PP not RB B-PP in IN I-PP Jurkat NN B-NP or CC O HeLa NN B-NP cells NNS B-NP . . O Furthermore RB B-ADVP COMMA COMMA O a DT B-NP mutant JJ I-NP E6 NN I-NP motif NN I-NP lost VBD B-VP both CC O in FW B-NP vitro FW I-NP binding NN I-NP activity NN I-NP and CC B-PP in FW B-NP vivo FW I-NP enhancer NN I-NP activity NN I-NP . . O In IN B-PP striking JJ B-NP contrast NN I-NP to TO B-PP the DT B-NP mouse NN I-NP Ig NN I-NP heavy-chain JJ I-NP enhancer NN I-NP COMMA COMMA O in IN B-PP which WDT B-NP the DT B-NP octamer NN I-NP motif NN I-NP acts VBZ B-VP as IN B-PP a DT B-NP B-cell-specific JJ I-NP enhancer NN I-NP element NN I-NP COMMA COMMA O the DT B-NP human JJ I-NP enhancer NN I-NP contains VBZ B-VP an DT B-NP octamerlike JJ I-NP sequence NN I-NP with IN B-PP one CD B-NP base NN I-NP substitution NN I-NP which WDT B-NP bound VBD B-VP octamer-binding JJ B-NP proteins NNS I-NP with IN B-PP only RB B-NP very RB I-NP low JJ I-NP affinity NN I-NP and CC O showed VBD B-VP no DT B-NP enhancer NN I-NP activity NN I-NP of IN B-PP its PRP$ B-NP own JJ I-NP . . O Interestingly RB B-ADVP COMMA COMMA O the DT B-NP MnlI-AluI NN I-NP fragment NN I-NP could MD B-VP suppress VB I-VP the DT B-NP basal-level JJ I-NP activity NN I-NP of IN B-PP the DT B-NP conalbumin JJ I-NP promoter NN I-NP in IN B-PP both CC O Jurkat NN B-NP and CC O HeLa NN B-NP cells NNS B-NP . . O Moreover RB B-ADVP COMMA COMMA O simian JJ B-NP virus NN I-NP 40 CD I-NP enhancer NN I-NP activity NN I-NP was VBD B-VP blocked VBN I-VP by IN B-PP the DT B-NP MnlI-AluI NN I-NP fragment NN I-NP in IN B-PP HeLa NN B-NP cells NNS I-NP but CC B-PP not RB B-PP in IN I-PP B NN B-NP cells NNS I-NP . . O Thus RB B-ADVP COMMA COMMA O the DT B-NP novel JJ I-NP enhancer NN I-NP element NN I-NP identified VBN B-VP in IN B-PP this DT B-NP study NN I-NP is VBZ B-VP probably RB B-ADVP a DT B-NP target NN I-NP site NN I-NP for IN B-PP both CC B-NP positive JJ I-NP and CC I-NP negative JJ I-NP factors NNS I-NP . . O The DT B-NP NF NN I-NP kappa NN I-NP B NN I-NP independent JJ I-NP cis-acting JJ I-NP sequences NNS I-NP in IN B-PP HIV-1 NN B-NP LTR NN I-NP responsive NN B-ADJP to TO B-PP T-cell NN B-NP activation NN I-NP . . O The DT B-NP rate NN I-NP of IN B-PP transcription NN B-NP initiation NN I-NP directed VBN B-VP by IN B-PP the DT B-NP long JJ I-NP terminal JJ I-NP repeat NN I-NP ( ( O LTR NN B-NP ) ) O of IN B-PP HIV-1 NN B-NP increases VBZ B-VP in IN B-PP response NN I-PP to TO I-PP mitogenic JJ B-NP stimuli NNS I-NP of IN B-PP T NN B-NP cells NNS I-NP . . O Here RB B-ADVP we PRP B-NP show VBP B-VP that IN B-SBAR the DT B-NP response NN I-NP of IN B-PP the DT B-NP HIV-1 NN I-NP LTR NN I-NP may MD B-VP be VB I-VP governed VBN I-VP by IN B-PP two CD B-NP independent JJ I-NP sequences NNS I-NP located JJ B-ADJP 5' JJ B-NP to TO B-PP the DT B-NP site NN I-NP of IN B-PP transcription NN B-NP initiation NN I-NP sequences NNS I-NP that WDT B-NP bind VBP B-VP either CC O NFAT-1 NN B-NP or CC O NF NN B-NP kappa NN I-NP B NN I-NP . . O The DT B-NP rate NN I-NP of IN B-PP LTR-directed JJ B-NP gene NN I-NP expression NN I-NP increased VBD B-VP in IN B-PP response NN I-PP to TO I-PP treatment NN B-NP with IN B-PP either CC O a DT B-NP phorbol NN I-NP ester NN I-NP or CC O tumor NN B-NP necrosis NN I-NP factor NN I-NP alpha NN I-NP if IN B-SBAR either CC O the DT O NFAT-1 NN B-NP or CC O NF NN B-NP kappa NN I-NP B NN I-NP binding NN B-NP sites NNS I-NP were VBD B-VP deleted VBN I-VP COMMA COMMA O but CC O failed VBD B-VP to TO I-VP respond VB I-VP to TO B-PP these DT B-NP mitogenic JJ I-NP stimuli NNS I-NP if IN B-SBAR both DT B-NP sequences NNS I-NP were VBD B-VP absent JJ B-ADJP . . O The DT B-NP HIV-1 NN I-NP mutant JJ I-NP virus NN I-NP containing VBG B-VP both CC O NF NN B-NP kappa NN I-NP B NN I-NP and CC O NFAT-1 NN B-NP deletion NN B-NP was VBD B-VP able JJ B-ADJP to TO B-VP replicate VB I-VP although IN B-SBAR at IN B-PP a DT B-NP much JJ I-NP decreased VBN I-NP growth NN I-NP rate NN I-NP COMMA COMMA O while IN B-SBAR the DT B-NP deletion NN I-NP of IN B-PP NFAT-1 NN B-NP alone RB B-ADVP increased VBD B-VP the DT B-NP viral JJ I-NP growth NN I-NP rate NN I-NP in IN B-PP Jurkat NN B-NP cells NNS I-NP . . O Neither CC O deletion NN B-NP of IN B-PP NF NN B-NP kappa NN I-NP B NN I-NP nor CC O deletion NN B-NP of IN B-PP NFAT-1 NN B-NP decreased VBD B-VP activation NN B-NP of IN B-PP viral JJ B-NP replication NN I-NP by IN B-PP phorbol NN B-NP ester NN I-NP . . O Specific JJ B-NP depletion NN I-NP of IN B-PP the DT B-NP B-cell NN I-NP population NN I-NP induced VBN B-VP by IN B-PP aberrant JJ B-NP expression NN I-NP of IN B-PP human JJ B-NP interferon NN I-NP regulatory JJ I-NP factor NN I-NP 1 CD I-NP gene NN I-NP in IN B-PP transgenic JJ B-NP mice NNS I-NP . . O Interferons NNS B-NP ( ( O IFNs NNS B-NP ) ) O are VBP B-VP well RB I-VP known VBN I-VP both CC O as IN B-PP antiviral JJ B-NP proteins NNS I-NP and CC B-PP as IN B-PP potent JJ B-NP regulators NNS I-NP of IN B-PP cell NN B-NP growth NN B-NP and CC O differentiation NN B-NP . . O In IN B-PP fact NN B-NP COMMA COMMA O IFNs NNS B-NP inhibit VBP B-VP growth NN B-NP of IN B-PP various JJ B-NP normal JJ I-NP and CC I-NP transformed VBN I-NP cell NN I-NP types NNS I-NP . . O Previously RB B-ADVP COMMA COMMA O a DT B-NP nuclear JJ I-NP factor NN I-NP COMMA COMMA O IRF-1 NN B-NP ( ( O interferon NN B-NP regulatory JJ I-NP factor NN I-NP 1 CD I-NP ) ) O COMMA COMMA O which WDT B-NP binds VBZ B-VP to TO B-PP type NN B-NP I CD I-NP IFN NN I-NP and CC O some DT B-NP IFN-inducible JJ I-NP gene NN I-NP promoters NNS I-NP COMMA COMMA O was VBD B-VP identified VBN I-VP and CC O cloned VBN B-VP . . O Since IN B-SBAR the DT B-NP IRF-1 NN I-NP gene NN I-NP is VBZ B-VP both CC O virus NN B-NP and CC O IFN NN B-NP inducible JJ B-ADJP COMMA COMMA O an DT B-NP intriguing JJ I-NP issue NN I-NP is VBZ B-VP raised VBN I-VP as IN B-PP to TO I-PP whether IN B-SBAR the DT B-NP IRF-1 NN I-NP gene NN I-NP is VBZ B-VP functioning VBG I-VP in IN B-PP IFN-mediated JJ B-NP regulation NN I-NP of IN B-PP cell NN B-NP growth NN B-NP and CC O differentiation NN B-NP . . O In IN B-PP this DT B-NP study NN I-NP COMMA COMMA O we PRP B-NP generated VBD B-VP transgenic JJ B-NP mice NNS I-NP carrying VBG B-VP the DT B-NP human JJ I-NP IRF-1 NN I-NP gene NN I-NP linked VBN B-VP to TO B-PP the DT B-NP human JJ I-NP immunoglobulin NN I-NP heavy-chain JJ I-NP enhancer NN I-NP . . O In IN B-PP the DT B-NP transgenic JJ I-NP mice NNS I-NP COMMA COMMA O all PDT B-NP the DT I-NP lymphoid JJ I-NP tissues NNS I-NP examined VBN B-VP showed VBD B-VP a DT B-NP dramatic JJ I-NP reduction NN I-NP in IN B-PP the DT B-NP number NN I-NP of IN B-PP B NN B-NP lymphocytes NNS I-NP ( ( O B NN B-NP cells NNS I-NP ) ) O . . O Preparation NN B-NP and CC O analysis NN B-NP of IN B-PP bone NN B-NP marrow NN I-NP cells NNS I-NP from IN B-PP the DT B-NP chimeric JJ I-NP mice NNS I-NP indicated VBD B-VP that IN B-SBAR the DT B-NP bone NN I-NP marrow NN I-NP is VBZ B-VP the DT B-NP effective JJ I-NP site NN I-NP for IN B-PP specific JJ B-NP depletion NN I-NP of IN B-PP the DT B-NP B-cell NN I-NP population NN I-NP . . O In IN B-PP fact NN B-NP COMMA COMMA O transgenic JJ B-NP bone NN I-NP marrow NN I-NP cells NNS I-NP cocultured VBN B-VP with IN B-PP a DT B-NP bone NN I-NP marrow-derived JJ I-NP stromal JJ I-NP cell NN I-NP line NN I-NP revealed VBD B-VP an DT B-NP altered JJ I-NP B-cell NN I-NP maturation NN I-NP pattern NN I-NP . . O Identification NN B-NP and CC O cloning NN B-NP of IN B-PP TCF-1 NN B-NP COMMA COMMA O a DT B-NP T NN I-NP lymphocyte-specific JJ I-NP transcription NN I-NP factor NN I-NP containing VBG B-VP a DT B-NP sequence-specific JJ I-NP HMG NN I-NP box NN I-NP . . O CD3-epsilon NN B-NP expression NN I-NP is VBZ B-VP controlled VBN I-VP by IN B-PP a DT B-NP downstream JJ I-NP T NN I-NP lymphocyte-specific JJ I-NP enhancer NN I-NP element NN I-NP . . O We PRP B-NP report VBP B-VP the DT B-NP identification NN I-NP of IN B-PP a DT B-NP T NN I-NP cell-specific JJ I-NP transcription NN I-NP factor NN I-NP COMMA COMMA O TCF-1 NN B-NP COMMA COMMA O binding VBG B-VP to TO B-PP this DT B-NP element NN I-NP . . O The DT B-NP multimerized JJ I-NP recognition NN I-NP motif NN I-NP of IN B-PP TCF-1 NN B-NP constituted VBD B-VP a DT B-NP T NN I-NP cell-specific JJ I-NP enhancer NN I-NP . . O Subsequent JJ B-NP cloning NN I-NP of IN B-PP TCF-1 NN B-NP identified VBD B-VP three CD B-NP splice NN I-NP alternatives NNS I-NP . . O TCF-1 NN B-NP contained VBD B-VP a DT B-NP single JJ I-NP DNA-binding JJ I-NP HMG NN I-NP box NN I-NP most RBS B-ADJP closely RB I-ADJP related JJ I-ADJP to TO B-PP similar JJ B-NP boxes NNS I-NP in IN B-PP the DT B-NP putative JJ I-NP mammalian JJ I-NP sex-determining JJ I-NP gene NN I-NP SRY NN I-NP and CC B-PP in IN B-PP the DT B-NP Schizosaccharomyces FW I-NP pombe FW I-NP Mc NN I-NP mating NN I-NP type NN I-NP gene NN I-NP . . O TCF-1 NN B-ADVP mRNA NN I-ADVP was VBD B-VP expressed VBN I-VP uniquely RB B-ADVP in IN B-PP T NN B-NP lymphocytes NNS I-NP . . O